Insider · SEC Form 4 filer
Leslie Parrette
Past buys: 1 of 4 beat
Companies
Where they file as an insider
Innospec (IOSP) Director Latest filing Nov 10, 2026
Track record
Did their buys beat the typical stock?
Open-market buys5
Quarters checked 6 months later4
Beat the typical stock 1 of 4
Quarters too new to check1
1 of 4 checked quarters beat the typical stock. A past record is data, not a forecast.
Innospec (IOSP) Bought Nov 10, 2026 · $27.5K · 345 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
Innospec (IOSP) Bought Nov 14, 2025 · $25.2K · 340 shares Beat typical Dec 31, 2025 $76.54 → Jun 30, 2026 $81.39 · +6.3% (typical stock +4.7%)
Innospec (IOSP) Bought Aug 13, 2024 · $15.1K · 143 shares Behind typical Sep 30, 2024 $113.09 → Mar 31, 2025 $94.75 · −16.2% (typical stock −7.5%)
Innospec (IOSP) Bought May 16, 2024 · $24.9K · 189 shares Behind typical Jun 30, 2024 $123.59 → Dec 31, 2024 $110.06 · −10.9% (typical stock +3.9%)
Innospec (IOSP) Bought Feb 22, 2024 · $50.8K · 410 shares Behind typical Mar 31, 2024 $128.94 → Sep 30, 2024 $113.09 · −12.3% (typical stock +3.2%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.